Versatility and nuances of the architecture of haematopoiesis - Implications for the nature of leukaemia
- PMID: 22071138
- DOI: 10.1016/j.leukres.2011.10.010
Versatility and nuances of the architecture of haematopoiesis - Implications for the nature of leukaemia
Abstract
For many years there was a widely accepted picture of how a haematopoietic stem cell (HSC) gives rise to the multiple types of blood and immune cells. This described the general nature of stem and progenitor cells and the pathways of cell development. Recent years have seen many attempts to re-draw the map of haematopoiesis. These have become increasingly complex, and they often envisage multiples routes to some cell types. The 'established' view that self-renewal in haematopoiesis only occurs in HSCs has been challenged by the recognition of self-renewing HSC-derived progenitor cells that display at least some fate restriction. This evolution of how normal haematopoiesis is viewed has inevitable implications for understanding the origins, disease progression and classification of the leukaemias. In essence, some progenitor cells are now seen as possessing a larger repertoire of routes to end-fates than was previously thought. This leads one to ask whether leukaemia stem cells are equally or less versatile than their normal counterparts?
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
The versatility of haematopoietic stem cells: implications for leukaemia.Crit Rev Clin Lab Sci. 2010 Aug;47(4):171-80. doi: 10.3109/10408363.2010.530150. Crit Rev Clin Lab Sci. 2010. PMID: 21182396 Review.
-
The versatile landscape of haematopoiesis: are leukaemia stem cells as versatile?Crit Rev Clin Lab Sci. 2012 Sep-Dec;49(5-6):232-40. doi: 10.3109/10408363.2012.742487. Epub 2012 Nov 15. Crit Rev Clin Lab Sci. 2012. PMID: 23153117 Review.
-
Therapeutic implications of leukemia stem cell development.Clin Cancer Res. 2007 Jun 15;13(12):3439-42. doi: 10.1158/1078-0432.CCR-06-3090. Clin Cancer Res. 2007. PMID: 17575205 Review.
-
Hematopoietic developmental pathways: on cellular basis.Oncogene. 2007 Oct 15;26(47):6687-96. doi: 10.1038/sj.onc.1210754. Oncogene. 2007. PMID: 17934478 Review.
-
Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Oncotarget. 2015 Dec 22;6(41):43326-41. doi: 10.18632/oncotarget.6145. Oncotarget. 2015. PMID: 26498146 Free PMC article. Review.
Cited by
-
Higher-order orchestration of hematopoiesis: is cohesin a new player?Exp Hematol. 2012 Dec;40(12):967-73. doi: 10.1016/j.exphem.2012.09.010. Epub 2012 Sep 26. Exp Hematol. 2012. PMID: 23022223 Free PMC article. Review.
-
Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.PLoS One. 2017 Jul 5;12(7):e0179700. doi: 10.1371/journal.pone.0179700. eCollection 2017. PLoS One. 2017. PMID: 28678800 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical